Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Closed: May 26, 17:07 PM 2012  
VRX ELN HSP ALKS ACUR FLML 
 
 
  NYSE  7,534  18.032  Index Moved Down 



Processing
Collecting data for PETS

PetMed management performance

    
    

PetMed Express Inc.

 Stock@American Stock Exchange 
United States
    
Use PetMed Express Inc. management performance together with your assets to enhance returns of your portfolios as well as to check it against diversification policy that fits your risk preferences.
    
    

PetMed Management Effectiveness

The company has return on total asset (ROA) of 16.48 % which means that it generated profit of $16.48 on every $1 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 18.7 % meaning that it created $18.7 on every dollar invested by stockholders.

PetMed Profit Margins

The company has Profit Margin (PM) of 6.99 % which can be a sign that it executes well on its competitive strategies and has a good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 10.92 % which suggests for every dolor of sales it generated a net operating income of 0.11.

PetMed Insiders

    
Menderes Akdag CEO and President Director and Member of Investment Committee
Robert Schweitzer Independent Chairman of the Board
Bruce Rosenbloom CFO, Principal Accounting Officer and Treasurer
Ronald Korn Independent Director
Frank Formica Independent Director
Gian Fulgoni Independent Director
Alison Berges Corporate Secretary and General Counsel
    

PetMed Express Inc. Workforce

    
PetMed Express Inc. is rated below average in number of employees category among related companies. The total workforce of Drug Delivery industry is at this time estimated at about 24,221. PetMed maintains roughly 204 in number of employees contributing less than 1% to equities under Drug Delivery industry.
    
    
Menderes Akdag  CEO
CEO and President Director and Member of Investment Committee
Mr. Menderes Akdag has served as President, Chief Executive Officer, Director of Petmed Express Inc. Mr. Akdag has served as the Company?s Chief Executive Officer since March 2001 and as President since August, 2005, and...
Robert Schweitzer  Chairman
Independent Chairman of the Board
Mr. Robert C. Schweitzer has served as Independent Chairman of the Board of Petmed Express Inc. Mr. Schweitzer has served as a member of Company Board of Directors since November 2002 and as Chairman of the Board since J...
    

Tenure Analysis

PetMed employes about 204 people. The company is managed by 7 executives with total tenure of roughly 53 years, averanging almost 7.0 years of service per executive having 29.0 employee per reported executive.

Return on PetMed Manpower

Revenue Per Employee 1.2 M
Revenue Per Executive 34 M
Net Income Per Employee 81.7 K
Net Income Per Executive 2.4 M
Working Capital Per Employee 367.4 K
Working Capital Per Executive 10.7 M

PetMed Earnings Per Share

According to company disclosure PetMed Express Inc. has Earnings Per Share of 0.8 times. This is 24.53% lower than that of Healthcare sector, and 53.85% higher than that of Drug Delivery industry, The Earnings Per Share for all stocks is 45.95% higher than the company.
Earnings per Share is one of the most important measures of current share price of a firm, and is used by investors to determine company overall profitability especially when it is compared to EPS of similar companies.

Discuss PetMed

    
    



 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting